Inhibition behavior of fructus psoraleae’s ingredients towards human carboxylesterase 1 (hCES1)

Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans

(2015) EK Tarkiainen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Fructus Psoraleae contains natural compounds with potent inhibitory effects towards human carboxylesterase 2

(2015) Yao-Guang Li et al.   FITOTERAPIA

In Vivo Screening for Anti-Osteoporotic Fraction from Extract of Herbal Formula Xianlinggubao in Ovariectomized Mice

(2015) Xinluan Wang et al.   PLoS One

A highly selective ratiometric fluorescent probe for in vitro monitoring and cellular imaging of human carboxylesterase 1

(2014) Zhao-Ming Liu et al.   BIOSENSORS & BIOELECTRONICS

Anti-dermatophytic activity of bakuchiol: In vitro mechanistic studies and in vivo tinea pedis-inhibiting activity in a guinea pig model

(2014) Kit-Man Lau et al.   PHYTOMEDICINE

Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis

(2013) Jiesi Xu et al.   HEPATOLOGY

Osteoblasts proliferation and differentiation stimulating activities of the main components of Fructus Psoraleae corylifoliae

(2013) Wei D. Li et al.   PHYTOMEDICINE

Carboxylesterase 1 (CES1) genetic polymorphisms and oseltamivir activation

(2012) Hao-Jie Zhu et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Es-x/Ces1 prevents triacylglycerol accumulation in McArdle-RH7777 hepatocytes

(2009) Kerry W.S. Ko et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Liver injury associated with the use ofFructus Psoraleae(Bol-gol-zhee or Bu-gu-zhi) and its related proprietary medicine

(2009) Wing I Cheung et al.   CLINICAL TOXICOLOGY

Human Carboxylesterases: An Update on CES1, CES2 and CES3

(2009) Sonal P. Sanghani et al.   PROTEIN AND PEPTIDE LETTERS